329 related articles for article (PubMed ID: 26874819)
21. A distinct profile of serum levels of soluble intercellular adhesion molecule-1 and intercellular adhesion molecule-3 in mycosis fungoides and Sézary syndrome.
López-Lerma I; Estrach MT
J Am Acad Dermatol; 2009 Aug; 61(2):263-70. PubMed ID: 19615537
[TBL] [Abstract][Full Text] [Related]
22. Cytologic evaluation of lymphadenopathy associated with mycosis fungoides and Sezary syndrome: role of immunophenotypic and molecular ancillary studies.
Pai RK; Mullins FM; Kim YH; Kong CS
Cancer; 2008 Oct; 114(5):323-32. PubMed ID: 18798522
[TBL] [Abstract][Full Text] [Related]
23. Prognostic significance of tumor burden in the blood of patients with erythrodermic primary cutaneous T-cell lymphoma.
Scarisbrick JJ; Whittaker S; Evans AV; Fraser-Andrews EA; Child FJ; Dean A; Russell-Jones R
Blood; 2001 Feb; 97(3):624-30. PubMed ID: 11157477
[TBL] [Abstract][Full Text] [Related]
24. Expression of T-follicular helper markers in sequential biopsies of progressive mycosis fungoides and other primary cutaneous T-cell lymphomas.
Bosisio FM; Cerroni L
Am J Dermatopathol; 2015 Feb; 37(2):115-21. PubMed ID: 25406852
[TBL] [Abstract][Full Text] [Related]
25. Sézary cell counts in erythrodermic cutaneous T-cell lymphoma: implications for prognosis and staging.
Vonderheid EC; Pena J; Nowell P
Leuk Lymphoma; 2006 Sep; 47(9):1841-56. PubMed ID: 17064997
[TBL] [Abstract][Full Text] [Related]
26. Defining early mycosis fungoides: validation of a diagnostic algorithm proposed by the International Society for Cutaneous Lymphomas.
Vandergriff T; Nezafati KA; Susa J; Karai L; Sanguinetti A; Hynan LS; Ambruzs JM; Oliver DH; Pandya AG
J Cutan Pathol; 2015 May; 42(5):318-28. PubMed ID: 25721994
[TBL] [Abstract][Full Text] [Related]
27. Utility of flow cytometry immunophenotyping and DNA ploidy studies for diagnosis and characterization of blood involvement in CD4+ Sézary's syndrome.
Lima M; Almeida J; dos Anjos Teixeira M; Queiros ML; Santos AH; Fonseca S; Balanzategui A; Justica B; Orfao A
Haematologica; 2003 Aug; 88(8):874-87. PubMed ID: 12935975
[TBL] [Abstract][Full Text] [Related]
28. TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the Cutaneous Lymphoma Task Force of the European Organization of Research and Treatment of Cancer (EORTC).
Kim YH; Willemze R; Pimpinelli N; Whittaker S; Olsen EA; Ranki A; Dummer R; Hoppe RT;
Blood; 2007 Jul; 110(2):479-84. PubMed ID: 17339420
[TBL] [Abstract][Full Text] [Related]
29. Update on erythrodermic cutaneous T-cell lymphoma: report of the International Society for Cutaneous Lymphomas.
Vonderheid EC; Bernengo MG; Burg G; Duvic M; Heald P; Laroche L; Olsen E; Pittelkow M; Russell-Jones R; Takigawa M; Willemze R;
J Am Acad Dermatol; 2002 Jan; 46(1):95-106. PubMed ID: 11756953
[TBL] [Abstract][Full Text] [Related]
30. Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC).
Olsen E; Vonderheid E; Pimpinelli N; Willemze R; Kim Y; Knobler R; Zackheim H; Duvic M; Estrach T; Lamberg S; Wood G; Dummer R; Ranki A; Burg G; Heald P; Pittelkow M; Bernengo MG; Sterry W; Laroche L; Trautinger F; Whittaker S;
Blood; 2007 Sep; 110(6):1713-22. PubMed ID: 17540844
[TBL] [Abstract][Full Text] [Related]
31. Overall survival in erythrodermic cutaneous T-cell lymphoma: an analysis of prognostic factors in a cohort of patients with erythrodermic cutaneous T-cell lymphoma.
Vidulich KA; Talpur R; Bassett RL; Duvic M
Int J Dermatol; 2009 Mar; 48(3):243-52. PubMed ID: 19261011
[TBL] [Abstract][Full Text] [Related]
32. Lymph node involvement by mycosis fungoides and Sézary syndrome mimicking angioimmunoblastic T-cell lymphoma.
LeBlanc RE; Lefterova MI; Suarez CJ; Tavallaee M; Kim YH; Schrijver I; Kim J; Gratzinger D
Hum Pathol; 2015 Sep; 46(9):1382-9. PubMed ID: 26193796
[TBL] [Abstract][Full Text] [Related]
33. Minimal residual disease monitoring with high-throughput sequencing of T cell receptors in cutaneous T cell lymphoma.
Weng WK; Armstrong R; Arai S; Desmarais C; Hoppe R; Kim YH
Sci Transl Med; 2013 Dec; 5(214):214ra171. PubMed ID: 24307695
[TBL] [Abstract][Full Text] [Related]
34. Paucity of FOXP3+ cells in skin and peripheral blood distinguishes Sézary syndrome from other cutaneous T-cell lymphomas.
Klemke CD; Fritzsching B; Franz B; Kleinmann EV; Oberle N; Poenitz N; Sykora J; Banham AH; Roncador G; Kuhn A; Goerdt S; Krammer PH; Suri-Payer E
Leukemia; 2006 Jun; 20(6):1123-9. PubMed ID: 16557241
[TBL] [Abstract][Full Text] [Related]
35. Heterogeneity of T-cell receptor expression at transformation in mycosis fungoides/Sezary Syndrome (MF/SS).
Jothishankar B; Venkataraman G; Goldberg RC; Abdulla F
Ann Diagn Pathol; 2019 Dec; 43():151404. PubMed ID: 31629155
[No Abstract] [Full Text] [Related]
36. Prognostic Significance of Serum Copper in Patients With Cutaneous T-cell Lymphoma.
Vonderheid EC; Martinez AR
Clin Lymphoma Myeloma Leuk; 2019 Apr; 19(4):228-238.e4. PubMed ID: 30745139
[TBL] [Abstract][Full Text] [Related]
37. Single TCR-Vβ2 evaluation discloses the circulating T cell clone in Sezary syndrome: one family fits all!
Scala E; Abeni D; Pomponi D; Russo N; Russo G; Narducci MG
Arch Dermatol Res; 2015 Aug; 307(6):487-93. PubMed ID: 25733488
[TBL] [Abstract][Full Text] [Related]
38. High expression of Dicer reveals a negative prognostic influence in certain subtypes of primary cutaneous T cell lymphomas.
Valencak J; Schmid K; Trautinger F; Wallnöfer W; Muellauer L; Soleiman A; Knobler R; Haitel A; Pehamberger H; Raderer M
J Dermatol Sci; 2011 Dec; 64(3):185-90. PubMed ID: 21937200
[TBL] [Abstract][Full Text] [Related]
39. Memorials and mandates for cutaneous lymphomas.
Heald PW
Arch Dermatol; 2003 Jul; 139(7):926-8. PubMed ID: 12873891
[No Abstract] [Full Text] [Related]
40. A modified staging classification for cutaneous T-cell lymphoma.
Kashani-Sabet M; McMillan A; Zackheim HS
J Am Acad Dermatol; 2001 Nov; 45(5):700-6. PubMed ID: 11606919
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]